It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

TEANECK, N.J.--(BUSINESS WIRE)--(NASDAQ: PAHC) The Food and Drug Administration (FDA), through its Center for Veterinary Medicine (CVM), has taken two actions regarding Mecadox ® (carbadox), a drug ...

JPMorgan upgraded Phibro Animal Health Corporation (NASDAQ:PAHC), citing strong execution following its $350 million acquisition of Zoetis' medicated feed additive and water-soluble product portfolio.

PAHC shares are up 90.9% this year, fueled by surging vaccine sales, new Brazil capacity and rapid growth across emerging ...

Pet parents may have struggled with a condition that affects 7% of all dogs — and up to 80% for breeds such as Cavalier King Charles spaniels. The condition is called mitral valve disease, which can ...

Phibro Animal Health Corporation’s PAHC focus on advancing vaccine technologies is poised to drive growth in the upcoming quarters. The company’s global growth prospects look encouraging. Yet, adverse ...

If you are wondering whether Phibro Animal Health's current share price lines up with its underlying worth, you are not alone ...

Phibro Animal Health PAHC has seen impressive momentum in the past year, with its shares soaring 82.8%. It has significantly outperformed the 9.6% rise of the industry and the S&P 500 Composite’s 26.7 ...

Phibro Animal Health Corp. entered into a definitive agreement to acquire Zoetis Inc.’s medicated feed additive product portfolio for $350 million. The New Jersey-based companies announced the ...